One of the leading producers and distributors for external-Chinese medicine in China - China Sky One Medical, Inc. (OTC: CSKI) - recently announced that three of its new diagnostic kits have passed the final stages of national inspection:

• AMI Diagnostic Kit: used for early diagnosis of Myocardial Infarction
  (MI) or heart disease.


• Human Urinary Albumin Elisa Kit: used for early diagnosis of nephropathy or kidney problems.


• Early Pregnancy Diagnostic Kit: uses monoclonal antibody technology to inform users if they are pregnant.

These diagnostic kits will then be issued new drug certificates and sold through drug stores, hospitals, examination stations and independent sales agents throughout China. The company also has plans of marketing the products in Vietnam, Indonesia, Philippines and eventually to Africa.

China Sky One Medical, Inc. is a Nevada corporation that through its subsidiaries is engaged in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic kit products.

Read the full report.